Clinical trials: Height Phobia
Phobic Disorders
D-Cycloserine to Enhance Cognitive Behavioral Therapy (CBT) for Acrophobia
The purpose of this study is to investigate the utility of post-session administration of D-cycloserine to enhance fear extinction in a sample of people with acrophobia who will be treated with CBT.
- Trial name
- NCT01102803
- Testing
- Individual Cognitive Behavioral Therapy (CBT), D-Cycloserine
- Where
- United States
- Volunteers
- 40 people, healthy volunteers welcome
- Sponsor
- Southern Methodist University
Height Phobia
D-Cycloserine-Enhancer of One-Session Treatment for Phobia of Heights
The study will determine the effects of D-Cycloserine (DCS) on fear reduction in patients diagnosed with phobia of heights (acrophobia) undergoing one session of three hours of virtual reality exposure therapy (VRET) or in vivo…
- Trial name
- NCT01037101
- Testing
- In Vivo Exposure Therapy, Virtual Reality Exposure Therapy, D-Cycloserine
- Where
- United States
- Volunteers
- 4 people, healthy volunteers welcome
- Sponsor
- CAMC Health System
Phobia
TMS Augmented Exposure Therapy
This study investigates the beneficial effects of prefrontal brain stimulation (with a facilitating TMS protocol) before exposure therapy in acrophobic patients. The two exposure sessions were realized in virtual reality.
- Trial name
- BEAT (NCT02223767)
- Testing
- Experimental: Verum TMS
- Where
- Germany
- Volunteers
- 47 people
- Sponsor
- Wuerzburg University Hospital